Pre-Clinical Study of a Novel Recombinant Botulinum Neurotoxin Derivative Engineered for Improved Safety.
about
Pre-Clinical Study of a Novel Recombinant Botulinum Neurotoxin Derivative Engineered for Improved Safety.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 03 August 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Pre-Clinical Study of a Novel ...... ngineered for Improved Safety.
@en
Pre-Clinical Study of a Novel ...... ngineered for Improved Safety.
@nl
type
label
Pre-Clinical Study of a Novel ...... ngineered for Improved Safety.
@en
Pre-Clinical Study of a Novel ...... ngineered for Improved Safety.
@nl
prefLabel
Pre-Clinical Study of a Novel ...... ngineered for Improved Safety.
@en
Pre-Clinical Study of a Novel ...... ngineered for Improved Safety.
@nl
P2093
P2860
P356
P1433
P1476
Pre-Clinical Study of a Novel ...... ngineered for Improved Safety.
@en
P2093
Aurelia Syngkon
Christopher Angeles
Edwin Vazquez-Cintron
Luis Tenezaca
Philip Band
Victoria Liublinska
P2860
P2888
P356
10.1038/SREP30429
P407
P577
2016-08-03T00:00:00Z
P6179
1044451645